EP0916621A2 - Wasser mit verbesserter Fähigkeit zum Dispergieren von Öl und Fetten - Google Patents
Wasser mit verbesserter Fähigkeit zum Dispergieren von Öl und Fetten Download PDFInfo
- Publication number
- EP0916621A2 EP0916621A2 EP98120550A EP98120550A EP0916621A2 EP 0916621 A2 EP0916621 A2 EP 0916621A2 EP 98120550 A EP98120550 A EP 98120550A EP 98120550 A EP98120550 A EP 98120550A EP 0916621 A2 EP0916621 A2 EP 0916621A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- water
- fine
- pure water
- composition
- clustered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 401
- 239000003925 fat Substances 0.000 title description 8
- 239000000203 mixture Substances 0.000 claims abstract description 107
- 239000008213 purified water Substances 0.000 claims abstract description 55
- 238000011282 treatment Methods 0.000 claims abstract description 53
- 239000003814 drug Substances 0.000 claims abstract description 50
- -1 contact lens cleaner Substances 0.000 claims abstract description 41
- 229940079593 drug Drugs 0.000 claims abstract description 39
- 239000000243 solution Substances 0.000 claims abstract description 28
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 claims abstract description 27
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 claims abstract description 27
- 229940117972 triolein Drugs 0.000 claims abstract description 27
- 239000002537 cosmetic Substances 0.000 claims abstract description 24
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 19
- 239000003889 eye drop Substances 0.000 claims abstract description 17
- 235000013305 food Nutrition 0.000 claims abstract description 14
- 239000003905 agrochemical Substances 0.000 claims abstract description 6
- 210000000713 mesentery Anatomy 0.000 claims abstract description 5
- 239000004567 concrete Substances 0.000 claims abstract description 4
- 239000008278 cosmetic cream Substances 0.000 claims description 36
- 239000002453 shampoo Substances 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 12
- 239000008341 cosmetic lotion Substances 0.000 claims description 8
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 210000004877 mucosa Anatomy 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 abstract description 13
- 210000001519 tissue Anatomy 0.000 abstract description 6
- 210000002200 mouth mucosa Anatomy 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 description 76
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 55
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 35
- 239000003921 oil Substances 0.000 description 35
- 235000019198 oils Nutrition 0.000 description 35
- 239000006071 cream Substances 0.000 description 27
- 238000002360 preparation method Methods 0.000 description 21
- 239000002904 solvent Substances 0.000 description 19
- 239000004094 surface-active agent Substances 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 239000002304 perfume Substances 0.000 description 16
- 239000000654 additive Substances 0.000 description 15
- 230000002421 anti-septic effect Effects 0.000 description 15
- 239000004902 Softening Agent Substances 0.000 description 14
- 239000003995 emulsifying agent Substances 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 239000002270 dispersing agent Substances 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 12
- 239000003906 humectant Substances 0.000 description 12
- 229960004063 propylene glycol Drugs 0.000 description 12
- 235000013772 propylene glycol Nutrition 0.000 description 12
- 239000003112 inhibitor Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 229940126585 therapeutic drug Drugs 0.000 description 11
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 10
- 210000001508 eye Anatomy 0.000 description 10
- 239000000919 ceramic Substances 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 239000003963 antioxidant agent Substances 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 239000000975 dye Substances 0.000 description 8
- 239000000049 pigment Substances 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 235000021355 Stearic acid Nutrition 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 230000003247 decreasing effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000003974 emollient agent Substances 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229940057995 liquid paraffin Drugs 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 7
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 7
- 239000008117 stearic acid Substances 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 239000000645 desinfectant Substances 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 230000001741 anti-phlogistic effect Effects 0.000 description 5
- 239000002518 antifoaming agent Substances 0.000 description 5
- 239000002216 antistatic agent Substances 0.000 description 5
- 235000013871 bee wax Nutrition 0.000 description 5
- 229940092738 beeswax Drugs 0.000 description 5
- 239000012166 beeswax Substances 0.000 description 5
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000001103 potassium chloride Substances 0.000 description 5
- 235000011164 potassium chloride Nutrition 0.000 description 5
- 239000000344 soap Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000003206 sterilizing agent Substances 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 235000017788 Cydonia oblonga Nutrition 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 229940124091 Keratolytic Drugs 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000002260 anti-inflammatory agent Substances 0.000 description 4
- 239000000739 antihistaminic agent Substances 0.000 description 4
- 229910021538 borax Inorganic materials 0.000 description 4
- 230000003750 conditioning effect Effects 0.000 description 4
- 239000000551 dentifrice Substances 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 230000001530 keratinolytic effect Effects 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 239000003973 paint Substances 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000004328 sodium tetraborate Substances 0.000 description 4
- 235000010339 sodium tetraborate Nutrition 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 229940099259 vaseline Drugs 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- 239000004129 EU approved improving agent Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000002981 blocking agent Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 239000003245 coal Substances 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 210000004087 cornea Anatomy 0.000 description 3
- 239000003599 detergent Substances 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 239000010696 ester oil Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229940012356 eye drops Drugs 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 239000010437 gem Substances 0.000 description 3
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 3
- 239000003752 hydrotrope Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005065 mining Methods 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000003223 protective agent Substances 0.000 description 3
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- 238000005165 17O NMR spectroscopy Methods 0.000 description 2
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 2
- WQNHWIYLCRZRLR-UHFFFAOYSA-N 2-(3-hydroxy-2,5-dioxooxolan-3-yl)acetic acid Chemical compound OC(=O)CC1(O)CC(=O)OC1=O WQNHWIYLCRZRLR-UHFFFAOYSA-N 0.000 description 2
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 150000003862 amino acid derivatives Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- 239000010426 asphalt Substances 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229920003086 cellulose ether Polymers 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000000882 contact lens solution Substances 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- 229940113120 dipropylene glycol Drugs 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229910001751 gemstone Inorganic materials 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000000976 ink Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000696 magnetic material Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 2
- 210000003928 nasal cavity Anatomy 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 238000005191 phase separation Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229940093625 propylene glycol monostearate Drugs 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 230000002940 repellent Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000005060 rubber Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- GEYJUFBPCGDENK-UHFFFAOYSA-M sodium;3,8-dimethyl-5-propan-2-ylazulene-1-sulfonate Chemical compound [Na+].CC(C)C1=CC=C(C)C2=C(S([O-])(=O)=O)C=C(C)C2=C1 GEYJUFBPCGDENK-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 229940021790 tetrahydrozoline hydrochloride Drugs 0.000 description 2
- BJORNXNYWNIWEY-UHFFFAOYSA-N tetrahydrozoline hydrochloride Chemical compound Cl.N1CCN=C1C1C2=CC=CC=C2CCC1 BJORNXNYWNIWEY-UHFFFAOYSA-N 0.000 description 2
- 239000004753 textile Substances 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- ZNVKGUVDRSSWHV-UHFFFAOYSA-L zinc;4-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=C(S([O-])(=O)=O)C=C1.OC1=CC=C(S([O-])(=O)=O)C=C1 ZNVKGUVDRSSWHV-UHFFFAOYSA-L 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 239000004265 EU approved glazing agent Substances 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- DJDFFEBSKJCGHC-UHFFFAOYSA-N Naphazoline Chemical compound Cl.C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 DJDFFEBSKJCGHC-UHFFFAOYSA-N 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003556 anti-epileptic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003173 antianemic agent Substances 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940075522 antidotes Drugs 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 229960004676 antithrombotic agent Drugs 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000467 autonomic pathway Anatomy 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- FWLORMQUOWCQPO-UHFFFAOYSA-N benzyl-dimethyl-octadecylazanium Chemical class CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 FWLORMQUOWCQPO-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 238000012662 bulk polymerization Methods 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000010000 carbonizing Methods 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 239000002817 coal dust Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 238000005108 dry cleaning Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 229960002534 ephedrine hydrochloride Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 206010015915 eye discharge Diseases 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007730 finishing process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000295 fuel oil Substances 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- ZFSXZJXLKAJIGS-UHFFFAOYSA-N halocarban Chemical compound C1=C(Cl)C(C(F)(F)F)=CC(NC(=O)NC=2C=CC(Cl)=CC=2)=C1 ZFSXZJXLKAJIGS-UHFFFAOYSA-N 0.000 description 1
- 229950006625 halocarban Drugs 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 208000021788 large intestine disease Diseases 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- SZINCDDYCOIOJQ-UHFFFAOYSA-L manganese(2+);octadecanoate Chemical compound [Mn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O SZINCDDYCOIOJQ-UHFFFAOYSA-L 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 239000006082 mold release agent Substances 0.000 description 1
- 238000010137 moulding (plastic) Methods 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 229940035363 muscle relaxants Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 229960004760 naphazoline hydrochloride Drugs 0.000 description 1
- OSZNNLWOYWAHSS-UHFFFAOYSA-M neostigmine methyl sulfate Chemical compound COS([O-])(=O)=O.CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 OSZNNLWOYWAHSS-UHFFFAOYSA-M 0.000 description 1
- 229960002253 neostigmine methylsulfate Drugs 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- ALSTYHKOOCGGFT-UHFFFAOYSA-N octadec-9-en-1-ol Chemical compound CCCCCCCCC=CCCCCCCCCO ALSTYHKOOCGGFT-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 208000024691 pancreas disease Diseases 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000010979 ruby Substances 0.000 description 1
- 229910001750 ruby Inorganic materials 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 1
- 229960005265 selenium sulfide Drugs 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008257 shaving cream Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229940077386 sodium benzenesulfonate Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229940048842 sodium xylenesulfonate Drugs 0.000 description 1
- LARLNXOUTTUXPN-UHFFFAOYSA-N sodium;(4-aminophenyl)sulfonyl-(5-methyl-1,2-oxazol-3-yl)azanide Chemical compound [Na+].O1C(C)=CC([N-]S(=O)(=O)C=2C=CC(N)=CC=2)=N1 LARLNXOUTTUXPN-UHFFFAOYSA-N 0.000 description 1
- MZSDGDXXBZSFTG-UHFFFAOYSA-M sodium;benzenesulfonate Chemical compound [Na+].[O-]S(=O)(=O)C1=CC=CC=C1 MZSDGDXXBZSFTG-UHFFFAOYSA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000003351 stiffener Substances 0.000 description 1
- 239000006190 sub-lingual tablet Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 229940098466 sublingual tablet Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- YZMCKZRAOLZXAZ-UHFFFAOYSA-N sulfisomidine Chemical compound CC1=NC(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 YZMCKZRAOLZXAZ-UHFFFAOYSA-N 0.000 description 1
- 229960001975 sulfisomidine Drugs 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920006174 synthetic rubber latex Polymers 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229940120293 vaginal suppository Drugs 0.000 description 1
- 239000006216 vaginal suppository Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/26—Processes using silver-salt-containing photosensitive materials or agents therefor
- G03C5/38—Fixing; Developing-fixing; Hardening-fixing
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B70/00—Preservation of non-alcoholic beverages
- A23B70/50—Preservation of non-alcoholic beverages by irradiation or electric treatment, without heating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B5/00—Water
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/005—Systems or processes based on supernatural or anthroposophic principles, cosmic or terrestrial radiation, geomancy or rhabdomancy
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B22/00—Use of inorganic materials as active ingredients for mortars, concrete or artificial stone, e.g. accelerators or shrinkage compensating agents
- C04B22/002—Water
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C1/00—Photosensitive materials
- G03C1/005—Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
- G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
- G03C5/26—Processes using silver-salt-containing photosensitive materials or agents therefor
- G03C5/29—Development processes or agents therefor
- G03C5/30—Developers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/48—Treatment of water, waste water, or sewage with magnetic or electric fields
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/48—Treatment of water, waste water, or sewage with magnetic or electric fields
- C02F1/481—Treatment of water, waste water, or sewage with magnetic or electric fields using permanent magnets
Definitions
- the present invention relates to water which has a superior ability to disperse oil and fats. More specifically, the present invention relates to water which can disperse at least about 1.5 times as much glyceryl trioleate (triolein) as pure water can; the use of the water; and the method for producing the water.
- glyceryl trioleate glyceryl trioleate
- Water is an important substance which is applicable to various field of industry. Especially, in the fields of pharmaceuticals, foods, cosmetics or detergents, water is mainly used as a solvent. In order to dissolve or disperse a substance (which is poorly soluble or insoluble in a solvent) in water, or in order to prepare an emulsion, a water-soluble solvent or surfactant must be added to water.
- the present inventors have conducted extensive studies on water and found out that the fine-clustered water from pure water can improve the solubility or dispersing ability of oil and fats, and thus accomplished the present invention.
- water which is able to disperse at least about 1.5 times as much glyceryl trioleate as purified water can, is provided, and thus the present invention can solve the above-mentioned problems.
- the present invention relates to fine clustered water from pure water which is obtained by a fine clustering treatment of pure water and is able to disperse at least about 1.5 times as much glyceryl trioleate as purified water is.
- the fine-clustered water from pure water of the present invention is able to disperse at least about 2 times as much glyceryl trioleate as purified water is.
- the fine-clustered water from pure water of the present invention is obtained by a fine clustering treatment of pure water.
- the fine-clustered water from pure water is obtained by treating pure water with magnetic field.
- Another invention is a method for producing the fine-clustered water from pure water which is able to disperse at least about 1.5 times as much glyceryl trioleate as purified water can, wherein the method comprises the step of a fine clustering treatment of pure water.
- the fine clustering treatment is a treatment with magnetic field.
- Yet another invention is a composition which comprises the fine-clustered water from pure water which is obtained by the fine clustering treatment of pure water and is able to disperse at least about 1.5 times as much glyceryl trioleate as purified water is.
- the fine-clustered water from pure water comprised in the composition is able to disperse at least about 2 times as much glyceryl trioleate as purified water is.
- the fine-clustered water from pure water is obtained by fine clustering treatment of pure water.
- the fine-clustered water from pure water is obtained by treating the pure water with magnetic field.
- the composition can be a pharmaceutical composition, cosmetic composition, food composition, eye drop composition, eye wash composition, contact lens cleaner, agricultural chemical composition, photo developing solution, or concrete composition.
- the absorption speed of a drug in the pharmaceutical composition via transdermal, mucosa or mesentery is faster than that of the case where the drug is in a pharmaceutical composition based on purified water.
- the present pharmaceutical composition is able to carry a drug faster than that of the case where the drug is in purified water.
- the composition can be a food composition for beverage use.
- the composition can be a cosmetic composition selected from the group consisting of cosmetic creams, cosmetic lotions, foundation, shampoo, treatments, and hair liquid.
- the fine-clustered water from pure water of the present invention is obtained by conducting a fine clustering treatment of pure water.
- pure water in the present specification means water obtained by desalting water, which is substantially pure and has a specific resistance of about 50 ⁇ ⁇ cm or more. Ultra pure water can also be included.
- purified water in the present invention means water obtained by distillation or ion exchange treatment.
- cluster means an aggregate of water molecules.
- the aggregate is formed by electric forces between water molecules (i.e., the hydrogen bond between oxygen and hydrogen).
- a fine clustering treatment means reducing the size of the cluster.
- the water which is used in the fine clustering treatment includes pure water, purified water (defined by Japanese Pharmacopoeia), service water, ion-exchanged water, and so on.
- Water other than pure water can be made into pure water by using any suitable method, such as ion-exchange treatment, distillation, ultrafiltration, reverse osmosis and any combination thereof.
- the water obtained by fine clustering treatment of pure water has not only a high ability to disperse oil and fats, but also improves the absorbability of a dissolved or dispersed substance.
- the water of the present invention has excellent drug delivery ability, which is not found in known water. Since purified water, service water, ion-exchanged water and so on may contain minerals (e.g., metal ions), the size of the cluster of water may not become sufficiently small.
- the fine-clustered water from pure water of the present invention can be obtained by treating pure water with magnetic field, very weak electric current, an electric field, ceramic plates, far infrared, high-frequency waves (electromagnetic waves), mechanical treatment, ultrasound, electromotive force, laser beams, or natural ore.
- the treatment can be used alone or in combination.
- Treatment with magnetic field can be performed by passing pure water with a certain speed (e.g., from about 10 to 20m/min) through a magnet apparatus.
- the magnet apparatus has magnets defining a gap having a magnetic field strength of about 0.07T or more (T: tesla; 1 tesla is 10,000gauss), and water is passed through the gap.
- T tesla; 1 tesla is 10,000gauss
- the treatment is performed using magnetic field 0.3T or more; most preferably 1.2T or more.
- the treatment using very weak electric current can be conducted by applying very weak electric current with several ten milliamperes to pure water running through a gap between an uninsulated internal electrode and an external electrode.
- the treatment using an electric field can be conducted by applying a DC or AC voltage of 1,000V or more to pure water in a storage tank.
- a DC or AC voltage of 1,000V or more can be applied to pure water in a storage tank.
- charcoal can be immersed in the storage tank.
- the treatment using ceramic plates can be done by immersing ceramic plates in pure water in a storage tank.
- the ceramic plates can be made from materials which can irradiate far infrared having a wavelength from about 6 to 14 ⁇ m.
- the treatment with far infrared includes a method of passing pure water through a ceramic filter which can irradiate far infrared, or a method of irradiating pure water with a far infrared heater.
- the principles of the method using the ceramic filter are substantially the same as that of the treatment with ceramic plate.
- the treatment with high frequency waves is a method of applying waves having a frequency higher than that of ultrasonic waves to pure water.
- This treatment includes microwave treatment, such as by electronic oven.
- the mechanical treatment includes a method of rotating pure water at high speed.
- the treatment with ultrasonic waves is to irradiate pure water with ultrasonic waves having a frequency from 20 to 40 KHz.
- the ultrasonic waves both high power and low power can be used.
- the high power ultrasonic waves can be used for cleaning jewels or glassware.
- the low power ultrasonic waves can be used for maturing Japanese sake and spirits.
- the electromotive force treatment is a method for making the cluster of the water small by using the difference of an ionization voltage.
- the difference of the ionization voltage is produced by passing pure water through the path defined by different electric conductive materials.
- the laser beam treatment can be performed by using various media that emit laser beams.
- water can be treated to irradiation with a gas laser (from 109.8nm of H 2 to 1990.75nm of CDCl 3 ), liquid laser, or solid laser (YAG laser, glass laser, ruby laser and so on).
- a gas laser from 109.8nm of H 2 to 1990.75nm of CDCl 3
- liquid laser from 109.8nm of H 2 to 1990.75nm of CDCl 3
- solid laser YAG laser, glass laser, ruby laser and so on
- the treatment using natural ore is a method of passing pure water through layers of natural ore with an appropriate pressure so as to make the cluster of the water small.
- the treatment with magnetic field is preferably conducted by using a water tank or water channel formed from non-magnetic material, which cross section having a slit-like structure.
- a pair of magnets are disposed on the longitudinal sides of the cross section of the water tank or the water channel so as to allow the different magnetic poles of the magnets to face each other, and the water is circulated through the water tank or the water channel.
- the pure water can be treated by irradiating the water stream with magnetic field, generated from the magnetic force generator, which are substantially perpendicular to the water stream.
- the magnetic generator both permanent magnets and electromagnets can be used.
- the permanent magnets are preferable in view of changing the magnets, and the electromagnet is preferable in view of being capable of easily generating high-power magnetic field.
- the magnetic force generator disposed in the apparatus comprises:
- the width of the slit is not limited; however, preferably, from about 0.1 mm to about 20 mm, more preferably, from about 0.5 mm to about 10 mm, or further preferably, about 2 mm.
- the temperature of the pure water to be treated and the pressure of treatment are not limited.
- the pure water is irradiated with magnetic field having an intensity from about 0.07T to about 15T; preferably, from about 0.3T to about 3T; and more preferably, from about 0.8T to about 2T.
- the magnets can be disposed in the water tank so that the different magnetic poles (N-S) of the magnets face each other and the gap between the magnets is filled with the pure water so that the pure water can be treated with magnetic field.
- the dispersing ability of the thus-obtained water can be measured by the following method. To each 10ml of the fine-clustered water and purified water, 43.5mg of glyceryl trioleate (Wako pure chemicals: purity 99% or more) is added, followed by shaking with 128rpm, for 5 minutes. Immediately after the shaking, 4 ml of the sample is recovered. A portion of the sample, 0.54ml, is put in a NMR sample tube of 5mm diameter. As an internal standard (standard material), 0.06ml of 10mM TSP-d 4 solution in heavy water is added. After adjusting the final concentration of TSP-d 4 to 1mM, 1 H-NMR measurement is performed. The concentration of glyceryl trioleate dispersed in the water can be calculated from the ratio of the signal intensity of the methylene group of the glyceryl trioleate and the methyl proton of TSP-d 4 .
- purified water As purified water, purified water (made by Wako pure chemicals, Japan) which conforms with the Japanese Pharmacopoeia is used.
- the fine-clustered water from pure water of the present invention has not only a high dispersing ability of oil and fats, but also improves the absorbability of a dissolved or dispersed substance; that is, the fine-clustered water from pure water of the present invention has a good drug delivery ability, which is not found in known water. Since the pure water which is a starting material of the present water contains few minerals (metal ions) which are usually contained in purified water, the size of the cluster of the fine-clustered water from pure water tend to be small. Furthermore, the resultant small sized clusters do not tend to aggregate to form largeclusters.
- the fine-clustered water from pure water of the present invention is believed to have a higher dispersing ability compared with the water obtained by purified water using a fine clustering treatment.
- the water of the present invention can be used preferably in pharmaceuticals, cosmetics, foods and so on.
- the water of the present invention was found to have not only a mere humective effect which prevents water from evaporating from the skin, but also to have excellent absorbability and permeation to skin tissues. Therefore, when the water of the present invention is used as a solvent for percutaneous absorbents or mucosal absorbents, these pharmaceuticals are dissolved easily in the water and are rapidly absorbed by tissue as compared to usual water (purified water). As a result, the effect that pharmaceuticals can be delivered rapidly is attained. For example, rapid absorption and delivery of drugs (pharmaceuticals) from (oral) mucosa, skin, or mesentery can be obtained. Further, rapid delivery of water and pharmaceuticals into blood can be obtained.
- the fine-clustered water from pure water of the present invention can be used for pharmaceutical preparations and can attain the above-mentioned effects.
- the fine-clustered water from pure water of the present invention can be used as a water component of, for example, an emulsifying agent, a dispersing agent and a solubilizing agent for internal and external medicine; a water soluble base or emulsifying base for ointments or suppositories; a liposome; an absorption-promoting agent for hard-absorbing medicine; an anesthetic medicine; a composition for artificial dialysis; a diagnostic agent; a composition for artificial blood; in eye drops and so on.
- the fine-clustered water from pure water of the present invention can be used to extract effective components of Chinese herbal remedies and so on.
- the fine-clustered water from pure water of the present invention can also be used for activation of the various reactions in a biological body.
- the fine-clustered water from pure water of the present invention can be used in cleaning cosmetics (cleansing creams, degreasers, soap, antibacterial soap and so on); fundamental cosmetics (cosmetic lotions, creams, milk lotions, face packs and so on); makeup cosmetics (foundation, lipsticks, cheek rouge, face powder and so on); cosmetics for hair (hair tonic, hair liquid and so on); bath soap or body care cosmetics (soap, body shampoo, shampoo, rinse, hair treatments and so on); and oral care cosmetics (tooth powder/paste, mouth wash and gargle).
- cleaning cosmetics cleaning creams, degreasers, soap, antibacterial soap and so on
- fundamental cosmetics cosmetic lotions, creams, milk lotions, face packs and so on
- makeup cosmetics foundation, lipsticks, cheek rouge, face powder and so on
- cosmetics for hair hair tonic, hair liquid and so on
- bath soap or body care cosmetics soap, body shampoo, shampoo, rinse, hair treatments and so on
- oral care cosmetics teeth
- the fine-clustered water from pure water of the present invention can be used in emulsified food, oily food, soup (for example, Chinese noodles), emulsifiers, dispersing agents, stabilizing agents for emulsified food, antifoaming agents, viscosity decreasing agents, anti-separation agents for whey, spreaders, film forming /or glazing agents on the epidermis of fruit and/or vegetables, stabilizing agents, anti-aging agents, anti-sticking agents, air holding agents, anti-brooming agents, dough adjusting and improving agents, decreasers for absorption of oil, dispersing agents for essence or spice, tissue improving agents, sun exposure improvers, solubilizers, flexibility improving agents, capacity increasing agents, whipping agents, soft drinks, beverages or juices (for example, canned coffee, concentrated vegetable juice and so on), potable water and so on.
- emulsifiers for example, Chinese noodles
- dispersing agents stabilizing agents for emulsified food, antifoaming agents,
- the fine-clustered water from pure water of the present invention can be used, for example, as a reagent for research purpose or for eye drop compositions, eye wash compositions, and contact lens cleaner; and can be used in the textile industry, agricultural, forestry and fishery industries, paper and pulp industries, cleaning industry, metal/machinery/noble metal/jewel industries, mining industry, leather industry, rubber/plastic industry, coloring material industry (such as pigments, paint, and ink), civil engineering/construction industry, ceramic industry, coal industry, petroleum/fuel industry, photographic industry, fermentation industry and so on.
- textile industry agricultural, forestry and fishery industries, paper and pulp industries, cleaning industry, metal/machinery/noble metal/jewel industries, mining industry, leather industry, rubber/plastic industry, coloring material industry (such as pigments, paint, and ink), civil engineering/construction industry, ceramic industry, coal industry, petroleum/fuel industry, photographic industry, fermentation industry and so on.
- the fine-clustered water from pure water of the present invention can be used in reagents for genetic engineering and protein engineering, reagents for extracting biological materials, reagents for organic synthesis, reagents for various analysis and so on.
- the fine-clustered water from pure water of the present invention can be used in agents for the treatment of eye disease and so on.
- eye wash can be used.
- the fine-clustered water from pure water of the present invention can be used in both soft and hard contact lens cleaners.
- the fine-clustered water from pure water of the present invention can be used in, for example, spinning oil agents, knitting oil, sizing oil, de-gumming cleaners, marcerizing agents, alkaline treatment agents for polyester fiber, bleaching agents, carbonizing agents, milling agents, dyeing assistant auxiliaries, dye dispersing agents, softening agents for bathing, soaping agents after dyeing, decolorizing agents, finishing agents, softening agents, softening agents for resin processing, softening agents for water repellent, water and oil repellents, stain-proofing agents, anti-static agents, browning inhibitors and so on.
- the fine-clustered water from pure water of the present invention can be used in agricultural chemicals, emulsified agricultural chemicals, consolidation inhibitors, powdered chemicals, spreaders, additives for fertilizer, antifoaming agents, plant growth regulating preparations, canning, water for cultivation, water purifiers (for the activation of aerobic bacteria), water for breeding aquarium fish and so on.
- the fine-clustered water from pure water of the present invention can be used in digesting assistants, de-inking agents, pitch controller, anti-foaming agents, felt cleaner, paper strengthening agents, pigment dispersing agents, sizing agents, releasing agents, softening agents, slime controllers, anti-static agents, curling inhibitors and paper viscosity agents and for the improvement of water filtration.
- the fine-clustered water from pure water of the present invention can be used in cleaner compositions, cleaners for laundry, softening agents for laundry, solvents for dry cleaning, solvents for wet cleaning, and solvents for special cleaning.
- the fine-clustered water from pure water of the present invention can be used in surface cleaners such as acid or alkali cleaners, solvents such as emulsifying solvents or emulsions, cleaners, anti-corrosive compositions, cleaners for precision instruments, cleaners for semiconductors and so on.
- the fine-clustered water from pure water of the present invention can be used in floatation concentrators such as foaming agents, collecting agents or absorbers of the collecting agents, coarse particulate eliminators, surface treatment preparations for ore, ignition inhibitors, heavy fluid stabilisers in dressings of ore or coal and so on.
- floatation concentrators such as foaming agents, collecting agents or absorbers of the collecting agents, coarse particulate eliminators, surface treatment preparations for ore, ignition inhibitors, heavy fluid stabilisers in dressings of ore or coal and so on.
- the fine-clustered water from pure water of the present invention can be used in the preliminary process (salting, soaking, liming, de-ashing, baking and de-fatting), tanning process (processing using plant tannin, chromium, mixed tannin and so on), coloring and fat addition processes, and finishing process (as a separating agent for use in mixing pigment with a wax glazing agent).
- the fine-clustered water from pure water of the present invention can be used in synthetic rubber latex, adhesion inhibitors, mold release agents, lubricants, inorganic reinforcing agents, agents for polymerization (such as emulsion polymerization agents, suspension polymerization agents and bulk polymerization agents), lubricants used in processing (for example, external and internal activators for improving fluidity), dispersing agents of the filler, anti-static agents, surface modifiers of the plastic moldings, anti-clouding agents, slipping agents, release agents, anti-blocking agents and so on.
- synthetic rubber latex adhesion inhibitors, mold release agents, lubricants, inorganic reinforcing agents, agents for polymerization (such as emulsion polymerization agents, suspension polymerization agents and bulk polymerization agents), lubricants used in processing (for example, external and internal activators for improving fluidity), dispersing agents of the filler, anti-static agents, surface modifiers of the plastic moldings, anti-clouding agents, slipping agents
- the fine-clustered water from pure water of the present invention can be used in surface pigment improvers, hydrophilic hydrophilization agents, lipophilization agents, dispersing agents for hydrophilic pigments in paint, dispersing agents for lipophilic pigments in paint, color development improvers, browning inhibitors, and aids thereof, additives thereof and so on.
- the fine-clustered water from pure water of the present invention can be used in admixtures of cement (for example, air entraining agents (AE agents) and aids thereof, wetting agents, dispersing agents, improvers for fluidity, foaming agents and so on), cutback asphalt (for example, peeling inhibitors and so on), asphalt emulsions, emulsifiers, coarse particulate depressants, sedimentary and coagulating agents, soil improvers, agents for rapid drying and so on.
- cement for example, air entraining agents (AE agents) and aids thereof, wetting agents, dispersing agents, improvers for fluidity, foaming agents and so on
- cutback asphalt for example, peeling inhibitors and so on
- asphalt emulsions emulsifiers
- coarse particulate depressants for example, sedimentary and coagulating agents
- soil improvers for rapid drying and so on.
- the fine-clustered water from pure water of the present invention can be used in additives such as aids for powdering agents, dispersing agents, binders and plasticizers, additives for glaze or muffle painting, oil lubricants, protective colloid agents, anti-foaming agents and so on.
- the fine-clustered water from pure water of the present invention can be used in additives for COM, additives for CWS, coal dust inhibitors, detergents for mining petroleum, emulsion-destroying agents for crude oil, additives for fuel oil and so on.
- the fine-clustered water from pure water of the present invention can be used in photosensitive emulsions (emulsions for couplers), anti-static agents which are added to the developing agent, dispersing agent of water-insoluble additives such as couplers and antiseptics in photographic emulsions, inhibitors for patches by drying, solvents for developer and fixer, and so on.
- photosensitive emulsions emulsions for couplers
- anti-static agents which are added to the developing agent
- dispersing agent of water-insoluble additives such as couplers and antiseptics in photographic emulsions
- inhibitors for patches by drying solvents for developer and fixer, and so on.
- the fine-clustered water from pure water of the present invention can be used in sterilizing agents, disinfectant, defoaming agents, productivity (yield) increasing agents, maturation promoting agents, fermentation promoting agents and so on.
- compositions of the present invention are described. Since the pharmaceutical compositions of the present invention use fine-clustered water from pure water which has superior dispersing ability, the drugs are not only dissolved easier in the water but also absorbed easily by tissues, and therefore the drugs are rapidly carried or delivered to the desired site. Thus, there is no limitation to the drugs that can be used in the pharmaceutical compositions.
- compositions of the present invention can be prepared in a dosage form suitable for the following administration and application: oral administration (gastrointenstinal tract), mucosal application (eye, oral mucosa, throat, nasal cavity, bronchus or lung, intestine, cavity of lower half of body), application to body surface (skin, body cavity, trauma), and intravascular or intratissue administration (intravenous, intramuscle and subcutaneous administration).
- oral administration gastrointenstinal tract
- mucosal application eye, oral mucosa, throat, nasal cavity, bronchus or lung, intestine, cavity of lower half of body
- body surface skin, body cavity, trauma
- intravascular or intratissue administration intravascular or intratissue administration
- the dosage may take the form of a powder, granule, tablet for internal use, capsule, pill, elixir, syrup, limonade, aromatic water, emulsion, suspension, infusion, decoction, tincture for internal use, extract, or liquid extract.
- the dosage may take the form of an eye drop, eye ointment, and so on for the eye; sublingual tablet, buccal preparation, troche and so on for oral mucosa; gargles for throat; spray for nasal cavity; aerosol, inhalant and so on for bronchus or lung; enema and so on for intestine; and suppository, vaginal suppository and so on for the lower body cavity.
- the dosage may take the form of an ointment, plaster, liniment, lotion, paste, cataplasm, liquid preparation, spirits, external tincture and so on for the skin.
- drench and so on can be used for the body cavity or trauma.
- the dosage may take the form of an injection for subcutaneous use, intramuscular use, intravenous use and so on; and implants for subcutaneous tissue.
- vehicle, adjuvant, additives and so on which are generally used in the preparation of pharmaceuticals can be added.
- the water of the present invention can be used as the water component for these vehicle, adjuvant, additives and so on.
- solvents As the vehicle, solvents, bases, diluents, bulking agents, fillers, excipients and so on can be used.
- solution adjuvants As the adjuvant, solution adjuvants, solubilizers, buffering agents, tonicity agents, emulsifiers, suspending agents, dispersants, thickeners, gelling agents, stiffening agents, absorbents, adhesives, elastomers, plasticizers, binders, disintegrants, tablet lubricants, coating agents, sustained release agents, aerosol propellants and so on can be used.
- antioxidants As the additives, antioxidants, preservatives, humectants, light protecting agents, polishing agents, anti-static agents, aroma, sweetening agents, flavors, colorants, emollients, soothing agents and so on can be used.
- drugs suitable for use in pharmaceutical composition are, for example: drugs for the circulatory system such as cardiotonic, pressor, anti-arrhythmic agents, therapeutic drugs for angina, vasodilator, hypotensive drugs, diuretic agents, hyperlipemia and so on; drugs for the respiratory system sucn as bronchiectasis, respiratory facilitate, therapeutic drugs for bronchial asthma, ntitussive, expectorants and so on; drugs for the digestive system such as drugs for stomachic digestion, drugs for peptic ulcers, drugs for controlling intestinal function, cathartic drugs, therapeutic drugs for large intestine disease, therapeutic drugs for hemorrhoidal disease and so on; therapeutic drugs for liver/pancreas/gall bladder diseases such as therapeutic drugs for the liver, therapeutic drugs for the pancreas, antidotes, cholagogue and soon; drugs for acting on the urinary organs/genitalia such as therapeutic drugs for the kidney and so on; drugs for acting on the nervous system such as somnifacients, sedatives, antipyretic anal
- the dosage form of pharmaceutical compositions can be prepared by any suitable method depending on their purpose.
- the cosmetic creams of the present invention include water which is obtainable by a fine clustering treatment of pure water and can disperse at least 1.5 times, preferably, at least two times as much glyceryl trioleate as purified water can.
- the fine-clustered water from pure water can disperse at most about five times as much glyceryl trioleate as purified water can.
- the cosmetic creams generally include emollient cream, massage cream, cleansing cream, makeup cream, sunscreen cream, hair cream, deodorant cream, shaving cream, face cream, hand cream and body cream, which are classified by use, function, and site of application.
- the cosmetic creams include all of the above creams.
- the cosmetic creams can include, in addition to the water of the present invention, various components that are usually included in cosmetic creams such as an oil component, aqueous component, emulsifier and so on.
- oil component a natural oil component such as animal, plant or mineral oil or a synthetic oil component can be used.
- oil component from an animal or plant for example, bees wax, carnauba wax, candelilla wax, cacao butter, cetyl alcohol (1-hexadecanol), alkylstearate, lanolin, olive oil, camellia oil, caster oil, cotton oil, 9-octadecene-1-ol (oleil alcohol), oleic acid, squalane and so on can be used.
- mineral oil component solid paraffin, ceresin, microcryatalline wax, wax, vaseline, liquid paraffin, silicone oil and so on can be used.
- synthetic oil component synthetic ester oil, synthetic polyether oil and so on can be used.
- the above oil component can be included in the cream, for example, from about 10 % to 80 % by weight.
- the content of the oil component depends on the types of creams such as oily, slightly oily, neutral and so on, and the amount to be added is determined accordingly.
- aqueous component humectants, viscosity-increasing agents, alcohol and so on can be used.
- the humectants may contribute to the moisture of the keratin, feeling of use and so on.
- humectants for example, glycerol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol, polyhydric alcohol, sugars, amino acids and so on can be used.
- humectants which can be added to the cosmetics are usually less than about 20 % by weight and preferably, less than about 15 % by weight.
- the viscosity-increasing agent may contribute to moisture, stability and feeling of use.
- the viscosity-increasing agent for example, quince seed (quince seed gum), gum tragacanth, pectin, alginate, cellulose derivatives such as sodium carboxymethyl-cellulose, acrylic polymers, veegum, polyvinyl alcohol and so on can be used.
- the alcohol may contribute by creating a refreshing feeling, sterilizing, dissolving the components and soon.
- the alcohol for example, ethanol, isopropanol and so on can be used.
- the fine-clustered water from pure water used for cosmetic composition of the present invention has superior dispersing ability, the amount of addition of the above mentioned humectants, viscosity-increasing agents, alcohol and so on can be decreased.
- the cosmetics using the present invention can contain appropriate amounts of other components such as softening agents (emollients), keratolytics, solubilizers, buffering agents, various drugs, perfume, antiseptics, dye, browning inhibitors, ultraviolet absorbers, metal ion blocking agents and so on.
- the softening agents may contribute to moisture, feeling of use and so on.
- the softening agent for example, ester oil, higher alcohols and so on can be used.
- alkalis for example, potassium hydroxide, potassium carbonate and so on, can be used.
- polyoxyethylene oleyl ether, octyl-dodecanol, lipophilic glycerol monostearate, self-emulsifying propylene glycol monostearate, polyoxyethylene cetyl ether, polyoxyethylenesorbitan monolaurylic acid ester and so on can be used.
- the emulsifier for example, octyldodecanol, can be added in an amount of from about 2 % to 8 % by weight, preferably, from about 3 % to 5 % by weight. Since the water used for cosmetic composition of the present invention has superior dispersing ability, the amount added of the above mentioned emulsifiers can be decreased.
- astringents such as zinc p-phenolsulfonate and so on, sterilizing agents such as benzalkonium chloride and so on, nourishing agents such as vitamins, amino acid derivatives and so on can be used.
- citric acid and salt thereof can be used as a buffer (pH adjusting agent).
- the cosmetic cream of the present invention is superior in keeping moisture.
- the ability for keeping moisture can be measured as follows: a certain amount of the sample is uniformly spread to facies anterior antebrachii of subjects, for example, spreading density being 1.25 ⁇ l/cm 2 ; after a certain period, the water content of the keratin layer is measured by high-frequency measuremeter of water in keratin.
- Shampoo and treatments using the present invention may include, in addition to the fine-clustered water from pure water of the present invention, from about 1 % to 40 % by weight of surfactants, foam increasing agents, hydrotropes (solubilizer), emulsifying agents, conditioning agents, alcohol, dandruff removing agents, sterilizing agents, tonic agents, softening agents (emollients), keratolytics, viscosity-increasing agents, chelating agents, various drugs, perfume, antiseptic, dyes, browning inhibitors, ultraviolet absorbers, metal ion blocking agents and so on.
- surfactants foam increasing agents
- hydrotropes solubilizer
- emulsifying agents conditioning agents
- alcohol dandruff removing agents
- sterilizing agents tonic agents
- softening agents emollients
- keratolytics viscosity-increasing agents
- chelating agents various drugs, perfume, antiseptic, dyes, browning inhibitors,
- any surfactant such as anionic, cationic, amphoteric and nonionic surfactant can be used.
- the surfactant can be contained in about 1 % to 40 % by weight. Since the fine-clustered water from pure water used in the shampoo or treatment is superior in dispersing activity, the amount of surfactant to be added can be decreased.
- alkylsulfate(AS), alkylether sulfate (AES), ⁇ -olefinsulfonate (AOS), soap, glycerin monoalkylester monosulfate, protein-fatty acid condensate, alkylphosphates and so on can be used.
- the cationic surfactant can also be used as a main component of a hair rinse composition.
- a cationic surfactant for example, alkyltrimethylammonium chloride, dialkyldimethylammonium chloride, alkyldimethylbenzylammonium chloride and so on can be used.
- amphoteric surfactant for example, a surfactant such as imidazolin type, alkylbetaine type, alkylbetainesulfone type and so on can be used.
- nonionic surfactant for example, alkanolamide, amine oxide and so on can be used.
- the foam increasing agent increases the foaming of the surfactant as a substrate of shampoo.
- alkanolamide of fatty acid, fatty acids, higher alcohol, water-soluble polymermolecules and so on can be used.
- the viscosity-increasing agent may contribute to moisture, stability and feeling of use.
- the viscosity-increasing agent for example, quince seed (quince seed gum), gumtragacanth, pectin, arginate, cellulosederivatives (such as sodium carboxymethylcellulose), acrylic polymers, veegum, polyvinyl alcohol and electrolytes (such as sodium chloride, potassium chloride) and so on can be used.
- the hydrotrope may contribute to low temperature stability of shampoo and to increased solubility of the surfactant.
- alcohol such as ethanol (which can also be used as a sterilizing agent), propylene glycol, glycerol (which can also be used as humectants), nonionic solbilizing agents such as polyoxyethylenesorbitan monolaurate and polyethyleneglycol ester of fatty acid, sodium benzenesulfonate, sodium xylenesulfonate, urea and so on can be used.
- the emulsifying agent emulsifies the shampoo and may contribute to a feeling of high class, mildness and creaminess of the shampoo.
- the emulsifying agent for example, styrene polymer, polyvinylacetate and so on can be used.
- Manganese stearate, etyleneglycol monostearate, ethyleneglycol distearate, stearyl alcohol, fish scale flakes, titaneted mica and so on can be used as pearl brightners.
- the conditioning agent may contribute to ease of combing, improvement of dry, loose hair and wiry hair, ease of arrangement, strengthening of hair and so on.
- the conditioning agent for example, substances having chemical absorbability such as hydrolysate of collagen, amino acids, sodium 2-pyrrolidone-5-carbonic acid, milk casein, ovalbumin, lecithin, pantenol (vitamin B complex) and so on; lanolin, squalane, and derivatives thereof; liquid paraffin, vaseline, fatty acid, higher alcohol, ester, silicone oil and derivatives thereof; oily substance having physical absorbability such as oil and fats (for example, castor oil and olive oil); ionic absorbable cationic polymers such as cationic denatured cellulose ether derivatives, quaternary ammonium salt of polyvinylpyrrolidone derivatives, chlorinated distearyldimethylammoniumpolymer, alkylpolyethylene imine and so on can be used.
- the alcohol may contribute by creating a refreshing feeling, sterilizing, dissolving the components and soon.
- the alcohol for example, ethanol, isopropanol and so on can be used.
- dandruff removing agent for example, sulfur compounds such as sulfur, selenium sulfide, Zpt and so on, menthols, triclosan, halocarban, allantoin, salicylic acid and so on can be used.
- the humectants may contribute to moisture, feeling of use and so on.
- humectants for example, glycerol, propyleneglycol, dipropyleneglycol, 1,3-butyleneglycol, polyethyleneglycol, polyalcohol, sugars, amino acids, sorbitol and so on can be used.
- the softening agent may contribute to moisture, feeling of use and so on.
- the softening agent for example, ester oil, higher alcohol and so on can be used.
- alkalis such as potassium hydroxide and potassium carbonate can be used.
- astringents such as zinc p-phenolsulfonate and so on, sterilizing agents such as benzalkonium chloride and so on, nourishers such as vitamins and/or amino acid derivatives and so on can be used.
- citric acid and salts thereof can be used as a buffer agent (pH adjusting agent).
- the additive amounts of the aforementioned viscosity-increasing agents, alcohol and so on can be decreased.
- any suitable methods can be used for producing cosmetics, shampoo, hair treatment and/or hair liquid with the present invention.
- the eye drop composition of the present invention can include, in addition to the fine-clustered water from pure water, many kinds of components which are usually blended in eye drop compositions such as angiotonics, vitamins, cell activating agents, parasympathmimetics, antiphlogistics, antihistamines, sulfa drugs, cornea protecting agents, tear components, disinfectant, transparent keeping agents, and so on.
- eye drop compositions such as angiotonics, vitamins, cell activating agents, parasympathmimetics, antiphlogistics, antihistamines, sulfa drugs, cornea protecting agents, tear components, disinfectant, transparent keeping agents, and so on.
- an eye drop composition contains about 99 % by weight of water and about 1 % by weight of tear components and other components.
- angiotonic for example, ephedrine hydrochloride and naphazoline hydrochloride can be used.
- vitamins for example, vitamin B2 complex, vitamin B6 composition, vitamin B12 composition, pantothenic acid and derivatives thereof and vitamin E can be used.
- cell activating agent for example, L-aspartic acid, allantoin, taurine and so on can be used.
- parasympathmimetic for example, neostigmine methylsulfate and so on can be used.
- the antiphlogistic depresses allergic reaction.
- the antiphlogistic for example, dipotassium glycyrrhizinate, tetrahydrozoline hydrochloride, lysozyme chloride, sodium azulenesulfonate and so on can be used.
- antihistamines for example, chlorpheniramine maleate, dipotassium glycyrrhizinate, and diphenhydramine hydrochloride can be used.
- the sulfa drug has anti-inflammatory action and anti-biotic action and therefore is effective with sites, bleary eyes and eye discharges.
- As the sulfa drug sulfamethoxazole, sodium sulfamethoxazole, sodium sulfisomidine and so on can be used.
- the cornea protecting agent for example, sodium chondroitin sulfate can be used.
- the tear component has functions which depress inflammation and protect the eyeball and cornea.
- sodium chloride, potassium chloride, calcium chloride can be used as the tear component.
- Sodium chloride can be included from about 0.5 % to about 0.75 % by weight.
- Potassium chloride can be included from about 0.07 % to about 0.2 % by weight. The sum of these two components may be from about 0.7 % to about 1.0 % by weight.
- polyvinyl alcohol can be used as a disinfectant.
- the eye drop composition of the present invention has superior drug penetration and absorption ability, so that highly effective treatment of an eye disease can be obtained.
- the contact lens cleaner contains water, enzymes such as proteolytic enzymes, surfactants, disinfectants, and other additives.
- the contact cleaner contains from about 80 % to about 99.9 % by weight of the water of the present invention and contains proteolytic enzymes and other necessary ingredients.
- NaCl can be contained from about 0.5 % to about 0.75 % by weight and KCl can be contained from about 0.07 % to about 0.2 % by weight. The sum of these two components can be contained from about 0.7 % to about 1.0 % by weight.
- the contact lens cleaner of the present invention is superior in affinity between the ingredients, and can be stored for a long time without forming any precipitate.
- protease various kinds of protease, proteolytic enzymes such as papain, mucin-decomposing enzyme, oil-and fat-decomposing enzymes such as lipase, and hyaluronic acid-decomposing enzymes such as hyaluronidase can be used.
- a nonionic surfactant is preferably used.
- the disinfectant polyethylene glycol and so on can be used.
- EDTA-2Na NaCl
- boric acid boric acid
- borax sodium carbonate anhydride
- sodium bicarbonate sodium bicarbonate
- citric anhydride sodium carbonate anhydride
- the contact lens cleaner of the present invention includes water with a superior dispersing ability, the amount of additives such as surfactants, disinfectants, and so on can be decreased. Further, the contact lens cleaner using the present invention can attain the effect that enzyme action in the cleaner is improved.
- the fine-clustered water was obtained by using the above-mentioned apparatus.
- the width of the water channel (slit) was 2mm and the rate of the water stream was about 15m/min.
- the circulating water was irradiated with magnetic field of intensity of 1.2T for 24 hours.
- the water used at the start was pure water or purified water.
- the thus-obtained the fine-clustered water from pure water, the fine-clustered water from purified water and purified water were subjected to 17 O-NMR measurement by the use of JNM EX-270 (Japan Electron Optics Laboratory Ltd.(JEOL. Ltd.)).
- the half width of 17 O-NMR signal at 20°C were as follows: the fine-clustered water from pure water 56.3Hz the fine-clustered water from purified water 83.7Hz purified water 142.4Hz
- the 1 H-NMR spectrum was measured by 128 times accumulated measurement by a 1 H Homo Gated Decoupling (HMG) method.
- the concentration of the dispersed glyceryl trioleate in the water was calculated from the ratio of the signal strength of the methylene group of the glyceryl trioleate and the signal intensity of the methyl proton of TSP-d 4 , an internal standard.
- the measurement was performed using JNM LA-400 FT-NMR Spectrometer of JEOL. Ltd.
- the relative intensity of the glyceryl trioleate dispersed in the fine-clustered water from pure water was about two times as much as that of purified water. Also, it was found that the relative intensity of the glyceryl trioleate dispersed in the fine-clustered water from purified water was only 1.1 times as much as that of purified water.
- Glyceryl monooleate was dispersed in the fine-clustered water from pure water, the fine-clustered water from purified water and purified water in the same manner as example 2, and observed by human eyes.
- phase separation was observed within 5 minutes; however, in the cases of the fine-clustered water from pure water and the fine-clustered water from purified water, an emulsion was retained for 24 hours and 2 hours, respectively, without phase separation. This shows that the fine-clustered water from pure water of the present invention has a superior oil-dispersing ability.
- Example alcohol solution Fifteen mature whister rats of seven weeks of age were prepared. Ethanol was dissolved in the fine-clustered water from pure water so that the concentration of ethanol was 16 % (the Example alcohol solution). As a comparative example, a 16 % ethanol solution was prepared in the fine clustered water from purified water (the Comparative Example alcohol solution). As a control, a 16% ethanol solution in purified water (the Control alcohol solution) was used. To each 5 rats, the Example alcohol solution, the Comparative Example alcohol solution and the Control alcohol solution were injected into the abdominal cavity at the ratio of 0.5g/Kg, respectively. Blood samples were collected at 30, 60, 90, 150 and 210 minutes after injection, respectively, and serum of each sample was prepared. The alcohol concentration of each sample was measured by 1 H-NMR.
- NMR was measured using JNM-EX400 (400MHz,9.3T) FT-NMR.
- Ethanol concentration (mM) was calculated by using 1mM dimethylsulfoxoide(DMSO) as an internal standard.
- the wide 1 H-NMR signals from protein were repressed by using the Carr-Purcell-Meiboom Gill pulse series for T 2 measurement, and the signal of water was repressed by the combination of the C-P-M Gill series and the Homo Gated Decoupling method, and was accumulated 16 times at intervals of 100 milisecond, repeat 15 seconds, at 30 °C.
- a cosmetic cream (cream type) having below-indicated composition was prepared as follows:
- Example 2 To the fine-clustered water from pure water obtained in Example 1, glycerol, propylene glycol and potassium hydroxide were added, and then mixed and stirred under heat (70°C) so as to obtain an aqueous component.
- Aqueous component water 60.5% alkali: potassium hydroxide 0.5% oil component: stearic acid 10% stearyl alcohol 4% butyl stearate 8% humectant: propylene glycol 10% glycerol 4% emulsifier: glycerol monostearate 3% perfume, antiseptic, antioxidant small amounts (total 100%)
- this cosmetic cream was still well emulsified and dispersed in the cosmetic cream even after one year from preparation.
- the cosmetic cream did not stick and was smooth and soft.
- the feeling of using this cream was good. Its ability to retain moisture was also superior.
- a cosmetic cream (cream type) was prepared in the same manner as that of example 5 except that purified water was used instead of the fine-clustered water from pure water.
- a cosmetic cream (cream type) having below-indicated composition was prepared as follows:
- Example 2 To the fine-clustered water from pure water obtained in Example 1, glycerol, propylene glycol and triethanolamine were added so as to obtain an aqueous component.
- bees wax, squalane, stearic acid and stearyl alchol were mixed to obtain an oil component which was kept at 70°C.
- perfume, antiseptic and an antioxidant were added to this oil component, stirred and mixed sufficiently so as to obtain an oily solution.
- this oily solution and the above aqueous component were mixed and stirred at 70°C so as to obtain a cosmetic cream.
- composition the percent is based on percent by weight.
- Aqueous component water 57.5% alkali: triethanolamine 1%
- oil component bees wax 2% stearic acid 8% stearyl alchol 5% squalane 10%
- humectant propylene glycol 8% glycerol 4%
- emulsifier self emulsifying propylene glycol monostearate 3% polyoxyethylenecetylether 1% perfume, antiseptic, antioxidant small amounts (total 100%)
- this cosmetic cream was still well emulsified and dispersed in the cosmetic cream even after one year from preparation.
- the cosmetic cream did not stick and was smooth and soft.
- the feeling of using this cream was good. Its ability to retain moisture was also superior.
- a cosmetic cream (cream type) having below-indicated composition was prepared as follows:
- Example 2 To the fine-clustered water from pure water obtained in Example 1, borax was added, stirred, and mixed and retained at 70°C under heat so as to obtain an aqueous component.
- bees wax and liquid paraffin were mixed and melted with heat and kept at 70°C so as to obtain an oil component. Then, this melted oil component and the above aqueous component were mixed and stirred at 70°C so as to obtain a cosmetic cream.
- composition the percent is based on percent by weight.
- Aqueous component water 39% borax 1%
- Oil component bees wax 10% liquid paraffin 50% (total 100%)
- this cosmetic cream was still well emulsified and dispersed in the cosmetic cream even after one year from preparation.
- the cosmetic cream did not stick and was smooth and soft.
- the feeling of using this cream was good. Its ability to retain moisture was also superior.
- a cosmetic cream (milk lotion type) having below-indicated composition was prepared as follows:
- Example 2 To the fine-clustered water from pure water obtained in Example 1, glycerol, propylene glycol, and triethanolamine were added, stirred, and mixed, and the thus-obtained aqueous component was retained at 70°C under heat.
- this oily solution and the above aqueous component were mixed and stirred at 70°C so as to obtain a cosmetic cream (milk lotion type).
- composition of the cosmetic cream (milk lotion type))
- composition the percent is based on percent by weight.
- Aqueous component water 70% glycerol 3% propylene glycol 5% triethanolamine 1%
- Oil component stearic acid 2% cethanol 1.5% vaseline 3% lanolinalcohol 2% liquid paraffin 10% perfume, antiseptic, antioxidant small amounts (total 100%)
- this cosmetic cream was still well emulsified and dispersed in the cosmetic cream even after one year from preparation.
- the cosmetic cream was spread on the skin, the cream did not stick and was smooth and soft. The feeling of using this cream was good.
- a cosmetic lotion having below-indicated composition was prepared as follows:
- Example 2 To the fine-clustered water from pure water obtained in Example 1, glycerol, propylene glycol and ultraviolet absorber were added, stirred, and mixed at an ambient temperature (25°C).
- composition the percent is based on percent by weight.
- Aqueous component water 79.7% humectant : glycerol 6% propylene glycol 4% softening agent: oleil alcohol 0.1% surfactant: polyoxyethylene lauryl ether 1% ethanol 10% perfume, antiseptic, antioxidant small amounts (total 100%)
- a foundation (cream type) having below-indicated composition was prepared by using the fine-clustered water from pure water obtained in Example 1.
- the percent is based on percent by weight.
- a hair liquid having below-indicated composition was prepared by using the fine-clustered water from pure water obtained in Example 1.
- the percent is based on percent by weight. water 31% polyoxypropylenebutylether 13% ethanol 56% disodium edetate small amount perfume, dye small amounts (total 100%)
- a shampoo (transparent type) having below-indicated composition was prepared by using the fine-clustered water from pure water obtained in Example 1.
- the percent is based on percent by weight. water 76% sodium alkylethersulfate 16% diethanolamide laurirate 4% propylene glycol 2% dye, antiseptic and ultraviolet absorber each appropriate amount (total 100%)
- this shampoo was still well emulsified and dispersed in this shampoo even after one year from preparation.
- the hair was soft.
- the feeling of using this shampoo was good.
- Shampoo was prepared in the same manner as that of example 12 except that purified water was used instead of the fine-clustered water from pure water.
- a shampoo (pearl type) having below-indicated composition was prepared by using the fine-clustered water from pure water obtained in Example 1.
- the percent is based on percent by weight.
- this shampoo was still well emulsified and dispersed in this shampoo even after one year from preparation.
- the hair was soft.
- the feeling of using this shampoo was good.
- a shampoo (conditioning type) having below-indicated composition was prepared by using the fine-clustered water from pure water obtained in Example 1.
- the percent is based on percent by weight. water 77% alkylether aminesulfate 18% coconut fatty acid diethanolamide 2% cationic denatured cellulose ether 1.5% perfume, dye, antiseptic appropriate amounts (total 100%)
- this shampoo was still well emulsified and dispersed in this shampoo even after one year from preparation.
- the hair was soft.
- the feeling of using this shampoo was good.
- a rinse having below-indicated composition was prepared by using the water obtained in Example 1.
- the percent is based on percent by weight.
- water 96% chlorinated stearyldimethylbenzylammonium 1.4% stearyl alchol 0.6% glycerine monostearate 1.5% sodium chloride 0.2% perfume, dye, antiseptic appropriate amounts (total 100%)
- this rinse was still well emulsified and dispersed in this shampoo even after one year from preparation. When this rinse was used, the hair was soft. The feeling of using this shampoo was good.
- a contact lens cleaner having below-indicated composition was prepared by using the fine-clustered water from pure water obtained in Example 1.
- the parts are based on weight. water 100 parts papain and neutral protease 18.5 parts lipase 1.4 parts hyaluronidase 1.4 parts lecithinase 1.4 parts nonionic surfactant 2.2 parts EDTA-2Na 4.3 parts Sodium chloride 12.9 parts sodium bicarbonate and citric anhydride 37.6 parts sodium carbonate anhydride 6.5 parts borax 8.6 parts polyethylene glycol 5.2 parts
- the components of the thus-obtained contact lens cleaner were homogeneously mixed even after one year from preparation, and it was able to be preserved for a long time without causing any precipitation.
- the amount of non-ioninc surfactant used was very low compared with that of conventional cleaner.
- a contact lens cleaner was prepared in the same manner as that of example 16 except that purified water was used instead of the fine-clustered water from pure water.
- Eye drops having below-indicated composition were prepared by using the fine-clustered water from pure water obtained in Example 1.
- the percent is based on percent by weight.
- tear component sodium chloride 0.7% potassium chloride 0.2%
- antiphlogistic sodium azulenesulfonate 0.02% tetrahydrozoline hydrochloride 0.02% antihistamine chlorpheniramine maleate 0.03%
- the components of the thus-obtained eye drop composition were homogeneously mixed even after one year from preparation, and it was able to be preserved for a long time without causing any precipitation.
- a dentifrice having below-indicated composition was prepared by using the fine-clustered water from pure water obtained in Example 1.
- the percent is based on percent by weight.
- the components of the thus-obtained dentifrice were homogeneously mixed, and the feeling of use was good.
- the amount of sodium laurylate used can be decreased.
- a developing solution and fixing solution for monochrome photography were prepared by using the fine-clustered water from pure water obtained in Example 1 and purified water as a control.
- the developer and the fixing agent were purchased from Fuji Film Company Limited (Japan).
- the developing solution and fixing solution were prepared according to the manufacturer's indication.
- the photographs developed and fixed by using the fine-clustered water from pure water were very clear, which could be recognized even by human eyes as compared with those developed using purified water. When these photographs were observed by the stereoscopic microscope, there was a significant difference in the clearness between them.
- the fine-clustered water from pure water of the present invention has a superior ability to disperse oil and fats and superior absorbancy by cells.
- the water of the present invention has the effect that, in a pharmaceutical field, drugs can be rapidly carried or delivered.
- the water of the present invention having the above features can also be applied to the food and cosmetic fields.
- Fine-clustered water made from pure water is obtained by fine clustering treatment of pure water and is able to disperse at least about 1.5 times as much glyceryl trioleate as purified water is.
- the water of the present invention can be used in pharmaceutical compositions, food compositions, cosmetic compositions, eye drop compositions, eye wash compositions, contact lens cleaner, agricultural chemical compositions, photo developing solution, and concrete compositions.
- the fine-clustered water of the present invention when used in pharmaceutical compositions, not only are the drugs dissolved easily in the water, but they are also rapidly absorbed via and delivered to tissue (oral mucosa, skin, mesentery) as compared with the purified water.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Inorganic Chemistry (AREA)
- Ceramic Engineering (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Geology (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Structural Engineering (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Physical Water Treatments (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Detergent Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31615897 | 1997-10-30 | ||
| JP316158/97 | 1997-10-30 | ||
| JP9316158A JPH11128951A (ja) | 1997-10-30 | 1997-10-30 | 油脂類の分散性に優れた水 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0916621A2 true EP0916621A2 (de) | 1999-05-19 |
| EP0916621A3 EP0916621A3 (de) | 1999-09-22 |
Family
ID=18073937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP98120550A Withdrawn EP0916621A3 (de) | 1997-10-30 | 1998-10-30 | Wasser mit verbesserter Fähigkeit zum Dispergieren von Öl und Fetten |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP0916621A3 (de) |
| JP (1) | JPH11128951A (de) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0988855A1 (de) * | 1998-01-28 | 2000-03-29 | Hee Jung Kim | Gesichtshautreinigungs- und Feuchtigkeitszusammensetzung |
| EP1065171A1 (de) * | 1999-06-17 | 2001-01-03 | Toshimitsu Hattori | Wasser mit hoher Polarität |
| WO2004044101A3 (en) * | 2002-11-14 | 2004-07-08 | Aaron Mcvitty | Improvements relating to fuel conditioning |
| AT412084B (de) * | 2001-05-18 | 2004-09-27 | Christian Hubacek | Vorrichtung zur veränderung von molekularen strukturen in flüssigkeiten |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001302461A (ja) * | 2000-04-24 | 2001-10-31 | Nonogawa Shoji Kk | 毛髪化粧料 |
| JP3758471B2 (ja) * | 2000-06-08 | 2006-03-22 | 横河電機株式会社 | ガス溶解装置 |
| JP2006213779A (ja) * | 2005-02-02 | 2006-08-17 | Ion Corporation Kk | 洗浄剤およびその製造方法 |
| JP5563745B2 (ja) * | 2007-04-04 | 2014-07-30 | 大正製薬株式会社 | 点眼剤 |
| JP5913670B1 (ja) * | 2015-03-26 | 2016-04-27 | 皆川 光雄 | 水の処理方法 |
| JP6255127B1 (ja) * | 2017-04-12 | 2017-12-27 | 株式会社ノエビア | 日焼け止め化粧料 |
| JP6255128B1 (ja) * | 2017-04-12 | 2017-12-27 | 株式会社ノエビア | 日焼け止め化粧料 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5711950A (en) * | 1990-01-12 | 1998-01-27 | Lorenzen; Lee H. | Process for preparing microclustered water |
| JP2865412B2 (ja) * | 1990-10-30 | 1999-03-08 | 眞 八藤 | 水の分子集団の細分化に使用する水溶性ミネラル含有液とその製造方法 |
| JPH07313859A (ja) * | 1994-05-24 | 1995-12-05 | Ryutaro Makise | 油類と水とのエマルシヨンの製造方法 |
| JP3315023B2 (ja) * | 1994-11-25 | 2002-08-19 | 服部 利光 | 磁化水製造用マグネット装置 |
| US5584994A (en) * | 1994-11-25 | 1996-12-17 | Hattori; Toshimitsu | Apparatus for manufacturing magnetized water and magnetic force generator used therefor |
| JPH08192172A (ja) * | 1995-01-13 | 1996-07-30 | Taisho Pharmaceut Co Ltd | 小クラスター水 |
| JPH08301773A (ja) * | 1995-05-10 | 1996-11-19 | Nendo Kagaku Kenkyusho:Kk | 皮膚掻痒症改善剤 |
| CN2271437Y (zh) * | 1996-04-10 | 1997-12-31 | 侯志纬 | 一种拌制混凝土活性水的制备装置 |
-
1997
- 1997-10-30 JP JP9316158A patent/JPH11128951A/ja active Pending
-
1998
- 1998-10-30 EP EP98120550A patent/EP0916621A3/de not_active Withdrawn
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0988855A1 (de) * | 1998-01-28 | 2000-03-29 | Hee Jung Kim | Gesichtshautreinigungs- und Feuchtigkeitszusammensetzung |
| EP1065171A1 (de) * | 1999-06-17 | 2001-01-03 | Toshimitsu Hattori | Wasser mit hoher Polarität |
| AT412084B (de) * | 2001-05-18 | 2004-09-27 | Christian Hubacek | Vorrichtung zur veränderung von molekularen strukturen in flüssigkeiten |
| WO2004044101A3 (en) * | 2002-11-14 | 2004-07-08 | Aaron Mcvitty | Improvements relating to fuel conditioning |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11128951A (ja) | 1999-05-18 |
| EP0916621A3 (de) | 1999-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100283793B1 (ko) | 지루 및/또는 여드름 치료의 유효성분으로서 화장품 및/또는 피부과학적 조성물에 사용되는 옥트옥시글리세롤의 용도 | |
| TWI257310B (en) | Topical delivery systems for active agents | |
| KR102544087B1 (ko) | 수율이 개선된 펩타이드 제조방법과 이를 이용한 화장료 조성물 | |
| JP2005534691A (ja) | コンブチャ(kombucha)を含む化粧品または皮膚用薬組成物 | |
| TW201343195A (zh) | 以非人類幹細胞之培養上清液為起始材料之化妝品或皮膚再生促進劑、及蛋白質之離子導入法 | |
| JP2008536797A (ja) | 表情皺を緩和するのに好適な皮膚投与のための美容組成物 | |
| JPH11333498A (ja) | 純水の製造方法 | |
| HAMBRICK et al. | Studies of the skin in Hurler's syndrome: mucopolysaccharidosis | |
| JPH10151468A (ja) | 表面張力が低下した水およびその利用 | |
| US20170035687A1 (en) | Skin treatment formulations | |
| JPH11128951A (ja) | 油脂類の分散性に優れた水 | |
| US20030035846A1 (en) | Water having a superior ability to disperse oil and fats | |
| CN112370393B (zh) | 一种洗发慕斯组合物及其制备方法与应用 | |
| CN117731544A (zh) | 一种含杏仁酸的具有靶向透皮递送功能的淡斑淡印美白增效组合物、其制备方法及其应用 | |
| KR20020027198A (ko) | 염증과 홍반의 완화방법 | |
| JP2003137768A (ja) | 抗老化剤 | |
| JPH05262635A (ja) | 皮膚外用剤 | |
| JP2002035761A (ja) | 油脂類の分散性に優れた水 | |
| CN105338978A (zh) | 用于促进胶原蛋白生成、促进弹性蛋白生成和/或促进角质形成细胞迁移的组合物及其应用 | |
| DE69607854T2 (de) | Sphingosylphosphorylcholin als wirkstoff zur wundheilung | |
| Suryani et al. | Peppermint essential oil nanoliposomes: Innovative formulation for effective hair growth | |
| CN114366693B (zh) | 一种婴童洗发沐浴露 | |
| JP2008088075A (ja) | プロフィラグリン/フィラグリン産生促進剤、表皮角化細胞増殖促進剤、表皮/角層正常化用皮膚外用剤、プロフィラグリン及び/又はフィラグリン産生促進方法、及び表皮角化細胞増殖促進方法 | |
| JP5649278B2 (ja) | ヒト成長ホルモンを有効成分として含む皮膚状態改善用組成物。 | |
| CN109091444A (zh) | 一种温和型美白祛痘洗面奶及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): CH DE GB LI |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
| AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| RIC1 | Information provided on ipc code assigned before grant |
Free format text: 6C 02F 1/48 A, 6A 23L 2/00 B, 6A 61K 7/00 B, 6A 61K 33/00 B, 6G 03C 5/30 B, 6C 04B 22/00 B, 6C 01B 5/00 B |
|
| 17P | Request for examination filed |
Effective date: 20000207 |
|
| AKX | Designation fees paid |
Free format text: CH DE GB LI |
|
| 17Q | First examination report despatched |
Effective date: 20010712 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20040504 |